Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36706347

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 May 1
First author
Patil VM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 May 1;41(13):2313-2318. doi: 10.1200/JCO.22.02350.
    note
    Source null
    related pmid
    36724418
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2023 Apr;20(4):210. doi: 10.1038/s41571-023-00740-7.
    note
    Source null
    related pmid
    36765156
    relationship
    Comment in

Authors and identifiers

  1. name
    Patil VM
    type
    Author
  2. name
    Noronha V
    type
    Author
  3. name
    Menon N
    type
    Author
  4. name
    Singh A
    type
    Author
  5. name
    Ghosh-Laskar S
    type
    Author
  6. name
    Budrukkar A
    type
    Author
  7. name
    Bhattacharjee A
    type
    Author
  8. name
    Swain M
    type
    Author
  9. name
    Mathrudev V
    type
    Author
  10. name
    Nawale K
    type
    Author
  11. name
    Balaji A
    type
    Author
  12. name
    Peelay Z
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Patil VM
    type
    Author
  2. name
    Noronha V
    type
    Author
  3. name
    Menon N
    type
    Author
  4. name
    Singh A
    type
    Author
  5. name
    Ghosh-Laskar S
    type
    Author
  6. name
    Budrukkar A
    type
    Author
  7. name
    Bhattacharjee A
    type
    Author
  8. name
    Swain M
    type
    Author
  9. name
    Mathrudev V
    type
    Author
  10. name
    Nawale K
    type
    Author
  11. name
    Balaji A
    type
    Author
  12. name
    Peelay Z
    type
    Author
bibliography ids
  1. nci-bib-bb798d1d8a789a2e58b051e0
book metadata
content sha256
3ee6bff8385d213730847367c29c6466bb45d06f0c2f2d88ffcccd8d31d2d307
document type
citation
dois
  1. 10.1200/JCO.22.00980
electronic publication date
display
2023 Jan 27
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36706347
immutable id
pubmed:36706347@3ee6bff8385d213730847367c29c6466bb45d06f0c2f2d88ffcccd8d31d2d307
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2350-2361
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 May 1;41(13):2313-2318. doi: 10.1200/JCO.22.02350.
    note
    Source null
    related pmid
    36724418
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2023 Apr;20(4):210. doi: 10.1038/s41571-023-00740-7.
    note
    Source null
    related pmid
    36765156
    relationship
    Comment in
outcomes validated
false
pmid
36706347
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
1e1110cd83110a0142c3ac368aedd9d42252ff2e5fd518b95d261ca28bce4b74
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 May 1
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Clinical Trial, Phase II
  4. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36706347/
title
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Preserved source evidence · Not medical advice